MRI brain scans for people with glaucoma
Part of Eyes & vision clinical trials.
This study uses MRI scans to look at brain structure in people with glaucoma compared to healthy controls. It aims to understand how glaucoma affects the brain over time, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have already taken part in and completed the ENVOL study.
- You need to have a valid health insurance in France.
- For people with glaucoma: you need a glaucoma diagnosis with an open drainage angle and some visual field loss.
- For people without glaucoma: you must have no personal or family history of glaucoma, normal eye pressure, and a normal visual field.
- You must be able to have an MRI scan (no pacemaker, cochlear implant, metal fragments, or claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced eye scans to compare the eyes of people with glaucoma against those with healthy eyes. It aims to find better ways to detect and monitor glaucoma, which could help preserve vision.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
This study measures how blood flows in the retina and how well the eye regulates that flow. It compares people with early or very early glaucoma to people without glaucoma to see what differences may predict progression.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.